Hope through Research

Patricia A. O'Looney, PhD

Progress in multiple sclerosis (MS) research is being made at a remarkable rate. Twenty years ago, very little was known about the regulation of the immune system, and before the approval of Betaseron® in 1993, no therapy had ever proved capable of changing the underlying course of MS. Now five approved, disease-modifying drugs are available to treat individuals with Ms. But the work in Ms research is not over. scientists are closer than ever to understanding the underlying cause of Ms, and finding additional treatments for all forms of Ms. Research efforts sponsored by the National Multiple Sclerosis Society (NMSS), the National Institutes of Health (NIH), private drug and biotechnology companies, and other Ms agencies around the world are contributing to this progress.

0 0

Post a comment